GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hero Technologies Inc (OTCPK:HENC) » Definitions » ROE %

Hero Technologies (Hero Technologies) ROE % : -3,051.85% (As of Sep. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Hero Technologies ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Hero Technologies's annualized net income for the quarter that ended in Sep. 2023 was $-1.65 Mil. Hero Technologies's average Total Stockholders Equity over the quarter that ended in Sep. 2023 was $0.05 Mil. Therefore, Hero Technologies's annualized ROE % for the quarter that ended in Sep. 2023 was -3,051.85%.

The historical rank and industry rank for Hero Technologies's ROE % or its related term are showing as below:

During the past 13 years, Hero Technologies's highest ROE % was 2.84%. The lowest was -15,485.71%. And the median was -5.21%.

HENC's ROE % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 4.26
* Ranked among companies with meaningful ROE % only.

Hero Technologies ROE % Historical Data

The historical data trend for Hero Technologies's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hero Technologies ROE % Chart

Hero Technologies Annual Data
Trend Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec20 Dec21 Dec22
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -15.54 -0.88 -137.49 - -15,485.71

Hero Technologies Quarterly Data
Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Mar18 Jun18 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2,872.73 - - - -3,051.85

Competitive Comparison of Hero Technologies's ROE %

For the Drug Manufacturers - Specialty & Generic subindustry, Hero Technologies's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hero Technologies's ROE % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hero Technologies's ROE % distribution charts can be found below:

* The bar in red indicates where Hero Technologies's ROE % falls into.



Hero Technologies ROE % Calculation

Hero Technologies's annualized ROE % for the fiscal year that ended in Dec. 2022 is calculated as

ROE %=Net Income (A: Dec. 2022 )/( (Total Stockholders Equity (A: Dec. 2021 )+Total Stockholders Equity (A: Dec. 2022 ))/ count )
=-0.542/( (0.078+-0.071)/ 2 )
=-0.542/0.0035
=-15,485.71 %

Hero Technologies's annualized ROE % for the quarter that ended in Sep. 2023 is calculated as

ROE %=Net Income (Q: Sep. 2023 )/( (Total Stockholders Equity (Q: Jun. 2023 )+Total Stockholders Equity (Q: Sep. 2023 ))/ count )
=-1.648/( (0.064+0.044)/ 2 )
=-1.648/0.054
=-3,051.85 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Sep. 2023) net income data. ROE % is displayed in the 30-year financial page.


Hero Technologies  (OTCPK:HENC) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Sep. 2023 )
=Net Income/Total Stockholders Equity
=-1.648/0.054
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-1.648 / 0)*(0 / 0.154)*(0.154 / 0.054)
=Net Margin %*Asset Turnover*Equity Multiplier
=N/A %*0*2.8519
=ROA %*Equity Multiplier
=N/A %*2.8519
=-3,051.85 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Sep. 2023 )
=Net Income/Total Stockholders Equity
=-1.648/0.054
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-1.648 / -1.648) * (-1.648 / -1.648) * (-1.648 / 0) * (0 / 0.154) * (0.154 / 0.054)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1 * 1 * N/A % * 0 * 2.8519
=-3,051.85 %

Note: The net income data used here is four times the quarterly (Sep. 2023) net income data. The Revenue data used here is four times the quarterly (Sep. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Hero Technologies ROE % Related Terms

Thank you for viewing the detailed overview of Hero Technologies's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Hero Technologies (Hero Technologies) Business Description

Traded in Other Exchanges
N/A
Address
8 The Green, Suite 4000, Dover, DE, USA, 19901
Hero Technologies Inc is a cannabis company with a vertically integrated business model and plan that includes cannabis genetic engineering, farmland for medical and recreational cannabis cultivation, production licenses, distribution licenses, consumer packaging, retail operations, and dispensaries. It focuses on two principal segments of the cannabis industry, cultivation, and the dispensary business model, including combinations.
Executives
Gina L. Serkasevich officer: CFO and Treasurer 310 COMMONS TRAIL LANE, HUFFMAN TX 77336
Keith Elliott Macdonald director 203 HERITAGE PLAVE, CALGARY A0 T3Z 3P3
K James Ebeling director 3726 WICKERSHAM LANE, HOUSTON TX 77027
James Douglas Brown director, 10 percent owner, officer: Secretary 11200 WESTHEIMER, SUITE 200, HOUSTON TX 77042
Holloman Value Holdings, Llc 10 percent owner 333 NORTH SAM HOUSTON PARKWAY EAST, SUITE 600, HOUSTON TX 77060
Robert Wesolek officer: Chief Financial Officer
Mark E. Stevenson director, officer: Secretary 8225 SAN DIEGO ST., ODESSA TX 79765
Eric C Prim director 4901 POLO PARKWAY, MIDLAND TX 79705
Grant M Petersen officer: Chief Executive Officer 1027 DAVIE ST., SUITE 482, VANCOUVER A1 V4E 1N9
Holloman Corp other: Affiliate 5257 WEST INTERSTATE 20, PO BOX 69410, ODESSA TX 79769
Holloman Oil & Gas Ltd. 10 percent owner 88 FORREST STREET, UNITS 8-9, COTTESLOE C3 6011
David R Lewis director 11115 EAST MONTGOMERY DRIVE, SUITE G, SPOKANE VALLEY WA 99206